VerdoiaMCassettiESchafferA; On behalf of the Novara Atherosclerosis Study Group (NAS). Relationship between glycoprotein IIIa platelet receptor gene polymorphism and coronary artery disease. Angiology. 2014;66(1):79–85.
2.
LefkovitsJPlowEFTopolEJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med. 1995;332(23):1553–1559.
3.
NewmanPJDerbesRSAsterRH. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest. 1989;83(5):1778–1781.
4.
BöttigerCKastratiAKochW. HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction. Thromb Haemost. 2000;83(4):559–562.
5.
ParkSParkHYParkC. Association of the gene polymorphisms of platelet glycoprotein Ia and IIb/IIIa with myocardial infarction and extent of coronary artery disease in the Korean population. Yonsei Med J. 2004;45(3):428–434.
6.
AmbroseJATannenbaumMAAlexopoulosD. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 1988;12(1):56–62.
7.
GoodmanTFerroASharmaP. Pharmacogenetics of aspirin resistance: a comprehensive systematic review. Br J Clin Pharmacol. 2008;66(2):222–232.
8.
AddadFElalamyIChakrounT. Platelet glycoprotein IIIa (platelet antigen 1/platelet antigen 2) polymorphism and 1-year outcome in patients with stable coronary artery disease. Blood Coagul Fibrinolysis. 2010;21(7):674–678.
9.
JalluVPoulainPFuchsPFKaplanCde BrevernAG. Modeling and molecular dynamics of HPA-1a and -1b polymorphisms: effects on the structure of the β3 subunit of the αIIb β3 integrin. PLoS One. 2012;7(11):e47304.
10.
AndrioliGMinuzPSoleroP. Defective platelet response to arachidonic acid and thromboxane A(2) in subjects with Pl(A2) polymorphism of beta(3) subunit (glycoprotein IIIa). Br J Haematol. 2000;110(4):911–918.
11.
LopesNHPereiraACHuebW. Effect of glycoprotein IIIa PlA2 polymorphism on outcome of patients with stable coronary artery disease and effect of smoking. Am J Cardiol. 2004;93(12):1469–1472.